Command Palette

Search for a command to run...

DRREDDY
1321.5(-0.09%)
1W: +2.43%

Peers

Snapshot Summary

Dr. Reddy's Laboratories Ltd. stands out in the pharmaceuticals sector with strong growth metrics, impressive profitability, and attractive valuation ratios. Compared to its peers, it shows significant advantages in revenue growth and return metrics, positioning it as a leader in the industry.

  • • Dr. Reddy's Laboratories has the highest 3-Year Revenue Growth at 13.72%.
  • • It exhibits robust profitability with a leading ROCE of 26.86%.
  • • Valuation metrics suggest Dr. Reddy's is undervalued with a PEG ratio of 0.19.
  • • Dr. Reddy's Laboratories Ltd.: Highest 3-Year Revenue Growth (13.72%) and strong profitability metrics.
  • • Mankind Pharma Ltd.: Strong growth trajectory with a 3-Year Revenue Growth of 155.25%.
  • • Cipla Ltd.: Solid ROE of 16.63% and low debt equity ratio.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02
ZYDUSLIFE₹990.65₹99,682.17Cr17.2624.90%0.04
Explore
Watchlists
Chat
Portfolio